Cytek Biosciences Inc — Cash Flow (NASDAQ:CTKB) | MetaTrader

Open full chart

Financials

Overview 明細書 Statistics Dividends

Quarterly Annual

Cash from operating activities 4.63 M12.23 M5.28 M25.38 M4.69 M 4.69 M Cash from investing activities 20.99 M55.91 M93.89 M82.97 M10.12 M 10.12 M Cash from financing activities 213.56 M5.51 M41.81 M15.82 M13.43 M 13.43 M Free cash flow 266 K2.36 M454 K21.65 M496 K 496 K

ニュース

Cytek Biosciences, Inc. (CTKB) Q4 2025 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Reports Q4 Loss, Tops Revenue Estimates

Cytek Biosciences earnings missed by $0.32, revenue topped estimates

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:CTKB) 2026-01-15

Cytek Biosciences, Inc. (CTKB) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Cytek Biosciences Is A Speculative Buy On Recurring Revenue Growth (CTKB)

Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday - Beyond Meat (NASDAQ:BYND), Avadel Pharmaceuticals (NASDAQ:AVDL)

Cytek Biosciences, Inc. (CTKB) Q3 2025 Earnings Call Transcript

Cytek Biosciences, Inc. (CTKB) Reports Q3 Loss, Tops Revenue Estimates

Alvotech (ALVO) Surges 8.6%: Is This an Indication of Further Gains?

Cytek Biosciences: Growth Over Profit Will Pay Off In The Long Term (NASDAQ:CTKB)

Cytek Biosciences at UBS Summit: Innovative Proteomics Insights